Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.

ABSTRACT:

Background

Limited evidence exists on the economic burden of individuals who progress from mild cognitive impairment (MCI) to Alzheimer disease and related dementia disorders (ADRD).

Objectives

To assess the all-cause health care resource utilization and costs for individuals who develop ADRD following an MCI diagnosis compared to those with stable MCI.

Design

This was a retrospective cohort study from January 01, 2014, to December 31, 2019.

Setting

The Merative MarketScan Commercial and Medicare Databases were used.

Participants

Individuals were included if they: (1) were aged 50 years or older; (2) had ≥1 claim with an MCI diagnosis based on the International Classification of Diseases, Ninth Revision (ICD-9) code of 331.83 or the Tenth Revision (ICD-1

SUBMITTER: Frech FH 

PROVIDER: S-EPMC11266270 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature